Bonum Certa Men Certa

European Patents Found to be Invalid and Deemed Impotent in the Highest British Court (Again)

It's about the tadalafil generic

Just gimme the hands



Summary: "Just gimme the patent," says every greedy corporation looking to ban its competition (including generics) and facilitate monopoly pricing; the problem is, the EPO keeps granting invalid patents that take a lot of time and money to formally invalidate (in courts), as Actavis v ICOS has just shown

THE number of patents granted by the U.S. Patent and Trademark Office (USPTO) declined last year after certainty associated with these patents had declined and then number of patent lawsuits had totally collapsed. We now see something similar going on in Europe. Was it inevitable? Couldn't we learn from the mistakes of American lawmakers and USPTO officials?



We are pleased to see that IP Kat (Rose Hughes) has recently been covering some cases that relate to the European Patent Office (EPO). Hughes is doing an OK job without coming across as a patent extremist like the Bristows staff at IP Kat and yesterday she wrote this article about a (British) Supreme Court outcome. Yet another EPO-granted patent has been found to be nonsense:

This morning, the UK Supreme Court delivered its decision in Actavis v ICOS [2019] USKC 15, upholding the Court of Appeal's decision that ICOS's dosage regimen patent was obvious. In doing so, the Supreme Court (in a welcome change...) has followed the previous approach of the lower courts to the question of inventive step in both the UK courts and in the jurisprudence of the EPO.

The patent in question related to tadalafil (branded as CIALIS). Tadalafil is an orally administered drug for treating sexual dysfunction. Tadalafil works in a similar way to Pfizer’s famous blockbuster drug Viagra, but with fewer side effects. The original first medical use patent for tadalafil (EP 0740668, "Daugan") and its associated SPC have both expired. The latest decision related to ICOS's patent (EP 1173181) which claimed a particular dosage regime of tadalafil. Lilly is the exclusive licensee of the patent.

In an attempt to clear the market for their own tadalafil generic, Actavis brought revocation proceedings against the ICOS/Lilly patent. Actavis argued that the claims lacked novelty and inventive step in view of the original tadalafil patent ("Daugan"). The contentious claims related to a dose regime of up to 5mg tadalafil per day. The Court of Appeal, in overturning Mr Justice Birss' decision, found the patent invalid for lack of inventive step (Actavis v ICOS [2017] EWCA Civ 1671). Particularly, it was found that the claimed dose would have been obvious for the skilled person to try (IPKat post here).


Notice that first comment which asks: "Can every one of Lord Hodge's 9 factors be accommodated within Lord Hodge's exposition of the EPO's Problem and Solution Approach? If not all, which ones not?"

“Can every one of Lord Hodge's 9 factors be accommodated within Lord Hodge's exposition of the EPO's Problem and Solution Approach?”
      --Anonymous
Someone "from France" then added: "One important factor seems indeed to be missing, which is the "reasonable expectation of success", even though certain of the listed factors are usually considered for applying this factor. The reasoning that the clinical trial is somewhat a "one way street" (to use EPO standards) is not completely out of scope, but the specific dosage finding that has been identified for optimal effect could, in my view, not have been necessarily derived from this approach (the dosage plateau could not have been expected, considering it seems to necessarily imply some hindsight). I'm not sure I agree with the comment in the post that such a decision is welcome..., I can hardly consider a diverging view between the EPO and national courts to be welcome."

Another anonymous commenter quotes: "The original first medical use patent for tadalafil (EP 0740668, "Daugan") and its associated SPC have both expired."

Then comes the question (or questions): "Doesn't this mean it has already passed through clinical trials? By the courts' logic should a 5mg dose already be known? What have I missed?"

What about public interests as well? Either way, the court has trashed yet another European Patent. Will António Campinos get the message or just keep on lying about quality?

“I can hardly consider a diverging view between the EPO and national courts to be welcome.”
      --Anonymous
Freshfields Bruckhaus Deringer LLP's Laura Whiting and Paul Abbott wrote about it this morning (publication time), calling it "its second patent decision in 6 months" (so rarely do we get to see, at least at this level, just how awful the quality of patents has become).

We'll probably hear a lot more about it in days if not weeks to come.

Recent Techrights' Posts

Skype is Dead, Microsoft Shuts It Down in a Few Months (for Good)
Many billions down the drain
[Video] Full Video of Richard Stallman's Talk Earlier This Month in Italy (Nexa, Turin)
We have a collection of them
Netcraft's New Web Server Survey Shows Microsoft Down in Every Category
That Microsoft is still visible in
Slopwatch: Anti-Linux Garbage and Fake 'Articles' About GNU and Linux, Courtesy of Serial Sloppers and Slopfarms
Today there is a frustrating amount of FUD online that wasn't published by humans but instead generated by LLMs
 
Links 28/02/2025: Mass Layoffs at Autodesk, Employee Burnout, and Measles in Texas
Links for the day
Gemini Links 28/02/2025: offpunk, Lagrange, and More
Links for the day
When the Business Goal is to Protect the Image of Criminals From the Mainstream Media or Free/Independent Press (at Any Cost)
What ever happened to the concept of "ethics" in this "legal" occupation?
It Has Been Over a Year Since Takedown Demands From Brett Wilson LLP, Nothing Has Been Taken Down
It backfired on the Serial Defamer
Links 28/02/2025: Domestic Violence Fatalities, Escalations Again Near Taiwan
Links for the day
IBM is Trading Employees for Revenue Acquired by Buying Companies and Growing the Debt
IBM's financial plan is corporate bulimia
Gemini Links 28/02/2025: Spring, cgi and inetd, Gemini Protocol FAQ
Links for the day
Over at Tux Machines...
GNU/Linux news for the past day
IRC Proceedings: Thursday, February 27, 2025
IRC logs for Thursday, February 27, 2025
What the LLM Scrapers Are Doing to Tux Machines
So far today it looks like we'll have served about 1.5 million requests at midnight. That's more than 50,000 per hour or 1,000 per minute.
Links 27/02/2025: Google Clown Computing Layoffs and Slack Goes Down as Usual
Links for the day
Links 27/02/2025: The Engagement Rehab and Another New Zine
Links for the day
Links 27/02/2025: Microsoft Trying Ads as Sales Fall, Preserving Data From Social Control Media a Real Problem
Links for the day
Hiding Crimes Against Women (i.e. Reputation Laundering) by Misusing Inapplicable Privacy Laws From Another Continent
As it turns out, "privacy" does not cover hiding illegal activities and if public information exists to prove these illegal activities, then it's perfectly OK to share it
Zurich CEO suicide, Martin Senn proximity to Adrian and Diana von Bidder-Senn, Debian
Reprinted with permission from Daniel Pocock
Debian, CentOS, RHEL source code demise now linked, accelerated after invalid trademark judgment
Reprinted with permission from Daniel Pocock
Civil Society Should Demand Removal of People Who Sought Removal of Richard Stallman
Perhaps it's noteworthy that the FSF is now being attacked (again)
RTO for You, But Not for Me: How IBM's Managers Try to Disguise Layoffs as "Resignations" or "Retirements"
What ever happened to corporate ethics?
Links 27/02/2025: Conflict Updates, Hacks Caught Red-Handed Misusing Licence to Exercise Law to Submit LLM Slop to Courts
Links for the day
Gemini Links 27/02/2025: Fuzzy Frontiers and New Arrivals at Geminispace
Links for the day
Over at Tux Machines...
GNU/Linux news for the past day
IRC Proceedings: Wednesday, February 26, 2025
IRC logs for Wednesday, February 26, 2025
From Strangling Women to SLAPPing Journalists (Microsoft in a Nutshell)
We won't ever capitulate to Microsofters who strangle women
Always Doing This Site for Principles, Not Money
Pro bono
The Short Lifecycle of Twitter Outrage
The upside is that the "tempo" of social control media is so fast (to cause addiction or "engagement" as the pushers put it) that the persistence of lies in social control media is rather poor
Microsoft Devoured the Open Source Initiative (OSI), Now It's Just a Chain of Blunders
The Open Source Initiative (OSI) is against openness
Chronological Index of Techrights
The index was created after Alex Oliva expressed interest
IBM employee from Zurich, Switzerland arrested, jailed for tunnel mistake that may have arisen due to sign colours
Reprinted with permission from Daniel Pocock
The Free Software Foundation's Fund-raising Efforts Continue Unabated (and With Positive Results)
Perhaps the cherry on the cake is that Microsoft influence agents now try to attack the people who run the FSF, for merely have the 'wrong' views on political affairs
Links 26/02/2025: Microsoft's "AI Value" Bubble is Blowing Up, Starbucks in Trouble as Well
Links for the day
Rumour About IBM Layoffs in the UK
That was 2 hours ago
Links 26/02/2025: Science, Hardware, and Politics
Links for the day
Timeline of Microsoft's 2025 Crisis and Growing Panic
Microsoft already had 3 waves of layoffs this year (not even 2 months have passed)
Slopwatch: Another Offending 'Linux' Site Found (Fake Articles About "Linux"), Postgres/PostgreSQL/PSQL Targeted by FUD from LLMs
It's all slop, as one can suspect
IBM Consulting: Layoffs Already in Progress
"What are the Deep Blue Thought Leaders World becoming? A rubbish heap?"
Over at Tux Machines...
GNU/Linux news for the past day
IRC Proceedings: Tuesday, February 25, 2025
IRC logs for Tuesday, February 25, 2025